BDTX Stock Posts

12/3/2025 3:51:45 PM

Unusual Option Volume

BDTX Black Diamond Therapeutics2.63-0.82 (-23.8%)

Black Diamond Therapeutics trades 2,296 contracts. The company has the following event: Webcast Presentation Highlighting Silevertinib Phase 2 Clinical Trial Results and Program Update on Dec 3, 2025. News: Black Diamond Therapeutics Announces Preliminary Phase 2 Data for Silevertinib in 1L NSCLC and Plans for a Phase 2 Trial of Silevertinib in GBM

3/20/2025 3:22:30 PM

Unusual Option Volume

BDTX Black Diamond Therapeutics1.90+0.18 (+10.5%)

Black Diamond Therapeutics trades 2,232 contracts.

3/19/2025 10:21:37 AM

Unusual Option Volume

BDTX Black Diamond Therapeutics2.25+0.57 (+33.9%)

9/23/2024 10:26:13 AM

Unusual Option Volume

BDTX Black Diamond Therapeutics5.16+0.40 (+8.4%)

9/23/2024 10:17:14 AM

BDTX 5.00+0.24 (+5.0%)Black Diamond Therapeutics

ATM straddle for 18-Oct-24 expiration returned a negative -61.0% from the previous business day
The upside wing (25 delta calls) declined -73.7%
Downside put (25 delta puts) lost -61.2%
The company has the following event: Investor Webcast Presentation on Sep 23, 2024.
The option volume for 18-Oct-24 expiration is 3,917
News: Black Diamond Therapeutics Announces Initial Phase 2 Data Demonstrating Robust Anti-tumor Activity of BDTX-1535 in Patients with Recurrent EGFRm NSCLC who Present with a Broad Spectrum of Classical, Non-classical, and C797S Resistance Mutations

9/20/2024 11:14:30 AM

Unusual Option Volume

BDTX Black Diamond Therapeutics4.74-0.04 (-0.8%)

Black Diamond Therapeutics trades 3,137 contracts.

Load Earlier Posts

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software